女性性别独立预测完整降主动脉瘤TEVAR术后死亡
本研究回顾性分析VQI注册数据库2011至2015年2574例因完整降主动脉瘤行TEVAR的患者,其中女性占40%。女性30天死亡率(5.4% vs 3.3%)和1年死亡率(9.8% vs 6.3%)均更高,校正年龄、主动脉尺寸指数、症状和合并症后,女性性别仍独立预测30天死亡(OR 1.5,95%CI 1.1-2.1,P<.01)和远期死亡(HR 1.3,95%CI 1.03-1.6,P=.02)。
要点
- 女性TEVAR术后30天死亡率5.4%高于男性3.3%。
- 校正混杂因素后女性性别独立预测30天死亡(OR 1.5)和远期死亡(HR 1.3)。
- 临床决定TEVAR干预时机时应考虑性别差异及破裂风险。
核心结论
- 校正年龄和合并症差异后,女性TEVAR术后围手术期死亡率更高且远期生存更差。
研究设计与样本
- 回顾性分析VQI注册数据库2011至2015年所有TEVAR病例,排除夹层、创伤和破裂,共纳入2574例患者(女性40%)。
主要发现
- 女性30天死亡率5.4% vs 男性3.3%(P<.01),1年死亡率9.8% vs 6.3%(P<.01)。
- 女性估计失血量>500mL比例20% vs 17%(P=.04),输血比例29% vs 21%(P<.001),髂动脉入路操作比例4.3% vs 2.1%(P<.01)。
- 女性中位住院时间5天 vs 4天(P<.001),ICU时间2.5天 vs 2天(P<.001),出院回家比例75% vs 86%(P<.001)。
- 校正年龄、主动脉尺寸指数、症状和合并症后,女性性别独立预测30天死亡(OR 1.5,95%CI 1.1-2.1,P<.01)和远期死亡(HR 1.3,95%CI 1.03-1.6,P=.02)。
临床怎么用
- 临床决定完整降主动脉瘤TEVAR干预时机时,应结合性别相关破裂风险考虑女性术后死亡风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Whereas sex differences in the pathogenesis, presentation, and outcomes of repair for abdominal aortic aneurysms are well studied, less is known about sex differences after thoracic endovascular aortic repair (TEVAR). The goal of this study was to evaluate the association between sex and morbidity and mortality after TEVAR. METHODS: A retrospective review of all TEVARs in the Society for Vascular Surgery Vascular Quality Initiative (VQI) registry from 2011 to 2015 was conducted, excluding those with dissection, trauma, and rupture. Statistical analysis was performed using the Fisher exact test and the Mann-Whitney U test for categorical and continuous variables. Multivariable logistic regression and Cox hazards modeling were used to account for differences in demographics, comorbidities, and aneurysm characteristics in 30-day mortality and long-term survival. RESULTS: We identified 2574 patients (40% women) who underwent TEVAR. Women were older, were less likely to be white, and had smaller aortic diameters but larger aortic size indices (aortic diameter/body surface area). Women also had more chronic obstructive pulmonary disease but less coronary artery disease and fewer coronary interventions. Women were more likely to be symptomatic at presentation and subsequently to have a nonelective procedure. Women had higher estimated blood loss >500 mL (20% vs 17%; P = .04), were more likely to be transfused (29% vs 21%; P < .001), and more frequently underwent iliac access procedures (4.3% vs 2.1%; P < .01). Operative time and left subclavian intervention were similar. Postoperatively, women had increased median hospital (5 vs 4 days; P < .001) and intensive care unit (2.5 vs 2 days; P < .001) lengths of stay and were less likely to be discharged home (75% vs 86%; P < .001). Mortality was higher for women at 30 days (5.4% vs 3.3%; P < .01) and 1 year (9.8% vs 6.3%; P < .01). After adjusting for age, aortic size index, symptoms, and comorbidities, female sex remained independently predictive of 30-day mortality (odds ratio, 1.5; 95% confidence interval, 1.1-2.1, P < .01) and long-term mortality (hazard ratio, 1.3; 95% confidence interval, 1.03-1.6; P = .02). CONCLUSIONS: Even after adjusting for differences in age and comorbidities, female patients have higher perioperative mortality and lower long-term survival after TEVAR. These findings, along with the rupture risk by sex, should be considered by clinicians in determining the timing of intervention.
引用
- Deery SE, Shean KE, Wang GJ, et al. Female sex independently predicts mortality after thoracic endovascular aortic repair for intact descending thoracic aortic aneurysms. J Vasc Surg. 2017. PMID: 28259576. doi:10.1016/j.jvs.2016.12.103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。